Autumn is here! Curl up with your favorite pumpkin-spiced blog and savor these stories harvested from the Drug Channels patch:
- Fresh insights about hospitals’ specialty drug profits
- SSR Update: Drug prices keep dropping
- My $0.02 on international benchmarking goes viral
- Amazon is finally disrupting CVS—but not how you expected
Plus, the best article ever about Elizabeth Holmes’s Theranos trial.
P.S. Please join the more than 12,500 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter. You can also find me on LinkedIn, where I have more than 20,000 followers.
My recent social media topics have included: the ASPE report, biosimilar reimbursement, non-profit hospital shenanigans, HRSA’s reorganization, MTM in Part D, PBMs’ GPOs, pharmacy GPOs, channel strategy, white bagging, and the soothing sounds of pills being counted.
Read more »
Source: Post feed
